Rockland Immunochemicals, Inc.
Rockland Immunochemicals, Inc., a leading provider in the biotechnology sector, is headquartered in the United States. Founded in 1965, the company has established itself as a key player in the development and production of high-quality antibodies, proteins, and immunoassay reagents. With a focus on research and diagnostic applications, Rockland serves a diverse clientele, including academic institutions, pharmaceutical companies, and clinical laboratories. Renowned for its extensive catalogue of custom and off-the-shelf products, Rockland Immunochemicals stands out due to its commitment to quality and innovation. The company has achieved significant milestones, including the introduction of unique antibody validation techniques that enhance research reliability. With a strong market position, Rockland continues to contribute to advancements in immunology and related fields, solidifying its reputation as a trusted partner in scientific discovery.
DitchCarbon Score
How does Rockland Immunochemicals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Rockland Immunochemicals, Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Rockland Immunochemicals, Inc.'s reported carbon emissions
Rockland Immunochemicals, Inc., headquartered in the US, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented Scope 1, 2, or 3 emissions to report. In the absence of specific emissions data, it is important to note that the company has not outlined any formal reduction targets or climate commitments. This lack of publicly available information suggests that Rockland Immunochemicals may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability and carbon footprint reduction, it will be essential for Rockland Immunochemicals to establish clear climate commitments and reduction initiatives to align with global standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Rockland Immunochemicals, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
